Brett Fishbin

Stock Analyst at KeyBanc

(0.86)
# 4,044
Out of 5,074 analysts
123
Total ratings
43.4%
Success rate
-2.6%
Average return

Stocks Rated by Brett Fishbin

NeuroPace
Sep 17, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $13.14
Upside: +36.99%
The Cooper Companies
Sep 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $61.65
Upside: -
ResMed
Aug 31, 2026
Reiterated: Buy
Price Target: $255 → $267
Current: $253.06
Upside: +5.51%
STERIS
Aug 17, 2026
Reiterated: Buy
Price Target: $269
Current: $232.22
Upside: +15.84%
Solventum
Aug 6, 2026
Reiterated: Buy
Price Target: $102
Current: $87.45
Upside: +16.64%
LeMaitre Vascular
Aug 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $85.33
Upside: -
Inspire Medical Systems
Aug 4, 2026
Reiterated: Hold
Price Target: n/a
Current: $72.66
Upside: -
Integer Holdings
Aug 3, 2026
Downgraded: Hold
Price Target: n/a
Current: $126.56
Upside: -
Kimball Electronics
Jul 2, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $25.01
Upside: -
LivaNova
Jun 22, 2026
Rated: Buy
Price Target: $81 → $92
Current: $81.27
Upside: +13.20%
Reiterated: Buy
Price Target: CHF 75.03 → CHF 72.56
Current: CHF 57.84
Upside: +25.44%
Reiterated: Buy
Price Target: $164
Current: $168.33
Upside: -2.57%
Reiterated: Hold
Price Target: n/a
Current: $18.13
Upside: -
Reiterated: Hold
Price Target: n/a
Current: $297.33
Upside: n/a